Teva Pharmaceuticals USA, Inc.

Cases where party is a Patent Asserter

Displaying 1 - 24 of 24

Only "example" cases are shown here, for full list contact Shawn Miller

Cases where party is an Alleged Infringer

Displaying 201 - 238 of 238
# Title Civil Action Venue Filing Date Asserter Categories Patent Asserter Alleged Infringer
201 GW RESEARCH LIMITED v. TEVA PHARMACEUTICALS, INC. et al 2:23-cv-00018 D.N.J.
  • 8 Product company
GW Research Limited
202 AXSOME THERAPEUTICS, INC. et al v. TEVA PHARMACEUTICALS, INC. 2:23-cv-01695 D.N.J.
  • 8 Product company
Axsome Therapeutics, Inc.
203 AXSOME THERAPEUTICS, INC. et al v. TEVA PHARMACEUTICALS, INC. 2:23-cv-01695 D.N.J.
  • 8 Product company
Antecip Bioventures II LLC
204 Bayer AG, et al v. Biovail Corporation, et al 3:01-cv-01205 D.P.R.
  • 8 Product company
Bayer AG
205 Bayer AG, et al v. Biovail Corporation, et al 3:01-cv-01205 D.P.R.
  • 8 Product company
Bayer Corporation
206 Bayer AG, et al v. Biovail Corporation, et al 3:01-cv-01206 D.P.R.
  • 8 Product company
Bayer AG
207 Bayer AG, et al v. Biovail Corporation, et al 3:01-cv-01206 D.P.R.
  • 8 Product company
Bayer Corporation
208 Bayer AG, et al v. Biovail Corporation, et al 3:01-cv-01206 D.P.R.
  • 8 Product company
Pfizer, Inc
209 CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. 3:04-cv-04030 D.N.J.
  • 8 Product company
Novartis Pharma AG
210 CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. 3:04-cv-04030 D.N.J.
  • 8 Product company
Celgene Corporation
211 CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. 3:04-cv-04030 D.N.J.
  • 8 Product company
Novartis Pharmaceuticals Corporation
212 CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. 3:06-cv-06154 D.N.J.
  • 8 Product company
Novartis Pharma AG
213 CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. 3:06-cv-06154 D.N.J.
  • 8 Product company
Celgene Corporation
214 CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. 3:06-cv-06154 D.N.J.
  • 8 Product company
Novartis Pharmaceuticals Corporation
215 SANOFI-AVENTIS U.S. LLC et al v. TEVA PARENTERAL MEDICINES, INC. et al 3:07-cv-02837 D.N.J.
  • 8 Product company
Debiopharm, SA
216 SANOFI-AVENTIS U.S. LLC et al v. TEVA PARENTERAL MEDICINES, INC. et al 3:07-cv-02837 D.N.J.
  • 8 Product company
Sanofi-Aventis U.S. LLC
217 SANOFI-AVENTIS U.S. LLC et al v. TEVA PARENTERAL MEDICINES, INC. et al 3:07-cv-02837 D.N.J.
  • 8 Product company
Sanofi-Aventis U.S. LLC
218 CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. 3:07-cv-04459 D.N.J.
  • 8 Product company
Celgene Corporation
219 CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. 3:07-cv-04459 D.N.J.
  • 8 Product company
Novartis Pharma AG
220 CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. 3:07-cv-04459 D.N.J.
  • 8 Product company
Novartis Pharmaceuticals Corporation
221 OTSUKA PHARMACEUTICAL CO., LTD. v. TEVA PHARMACEUTICALS USA, INC. et al 3:08-cv-01583 D.N.J.
  • 8 Product company
Otsuka Pharmaceutical Co., Ltd.
222 MERCK SHARP & DOHME PHARMACEUTICALS SRL v. TEVA PHARMACEUTICALS USA, INC. et al 3:09-cv-00233 D.N.J.
  • 8 Product company
MERCK SHARP & DOHME PHARMACEUTICALS SRL,
223 OTSUKA PHARMACEUTICAL CO., LTD. v. TEVA PHARMACEUTICALS USA, INC. et al 3:09-cv-05531 D.N.J.
  • 8 Product company
Otsuka Pharmaceutical Co., Ltd.
224 UNITED THERAPEUTICS CORPORATION v. TEVA PHARMACEUTICALS USA, INC. 3:14-cv-05498 D.N.J.
  • 8 Product company
United Therapeutics Corporation
225 BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al 3:15-cv-05982 D.N.J.
  • 8 Product company
Boehringer Ingelheim Pharma GMBH & Co. KG
226 BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al 3:15-cv-05982 D.N.J.
  • 8 Product company
Boehringer Ingelheim International GMBH
227 BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al 3:15-cv-05982 D.N.J.
  • 8 Product company
Boehringer Ingelheim Corporation
228 BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al 3:15-cv-05982 D.N.J.
  • 8 Product company
Boehringer Ingelheim Pharmaceuticals, Inc.
229 Galderma Laboratories LP v Actavis Laboratories UT Inc et al 3:17-cv-00903 N.D.Tex.
  • 8 Product company
Galderma SA
230 Galderma Laboratories LP v Actavis Laboratories UT Inc et al 3:17-cv-00903 N.D.Tex.
  • 8 Product company
Galderma Research & Development SNC
231 Galderma Laboratories LP v Actavis Laboratories UT Inc et al 3:17-cv-00903 N.D.Tex.
  • 8 Product company
Galderma Laboratories LP
232 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS USA, INC. et al 3:17-cv-11510 D.N.J.
  • 8 Product company
Boehringer Ingelheim International GMBH
233 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS USA, INC. et al 3:17-cv-11510 D.N.J.
  • 8 Product company
Boehringer Ingelheim Pharmaceuticals, Inc.
234 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS USA, INC. et al 3:17-cv-11510 D.N.J.
  • 8 Product company
Boehringer Ingelheim Pharma GMBH & Co. KG
235 GILEAD SCIENCES, INC. et al v. TEVA PHARMACEUTICALS USA, INC. 3:18-cv-04273 D.N.J.
  • 8 Product company
Gilead Pharmasset LLC
236 GILEAD SCIENCES, INC. et al v. TEVA PHARMACEUTICALS USA, INC. 3:18-cv-04273 D.N.J.
  • 8 Product company
Gilead Sciences, Inc.
237 CELGENE CORPORATION v. TEVA PHARMACEUTICALS USA, INC. et al 3:18-cv-11215 D.N.J.
  • 8 Product company
Celgene Corporation
238 Pozen Inc. v. Teva Pharmaceuticals USA Inc. 6:09-cv-00182 E.D.Tex.
  • 8 Product company
Pozen Inc.